关于喘管理指南的最新情况
Sarah Dubin1, Pooja Patak2, Diana Jung2
1Associate Professor of Medicine, Department of Pulmonary and Critical Care Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
Missouri medicine
|October 18, 2024
概括
2024年全球喘倡议 (GINA) 战略建议所有喘患者服用含有吸入性皮质类固醇 (ICS) 的药物,取代短效β-激动剂 (SABA) 单疗法. 个性化喘行动计划对于减少严重事件至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 公共卫生 公共卫生
背景情况:
- 全球喘倡议 (GINA) 每年提供基于证据的喘管理指南.
- 喘仍然是一个重要的全球健康问题,需要更新治疗策略.
研究的目的:
- 概述2024年GINA战略更新的主要建议.
- 强调偏好的喘治疗方案和管理方法的转变.
主要方法:
- 审查关于喘管理的最新科学证据.
- 由GINA委员会制定更新的治疗指南.
主要成果:
- 2024年GINA更新建议不要单独使用短效β-agonists (SABA) 治疗成人和青少年的喘.
- 首选治疗 (轨道1) 涉及需要的低剂量ICS-formoterol组合吸入器作为缓解剂.
- 替代治疗 (轨道2) 包括SABA作为缓解剂,使用单独的ICS吸入器.
结论:
- 所有患有喘的人都应该接受含有吸入性皮质类固醇 (ICS) 的药物.
- 个性化喘行动计划和量身定制的管理对于尽量减少喘恶化,死亡和住院治疗至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


